A increasing body of study reveals distinct differences between cancer support systems in the America and Europe. While both regions strive to enhance patient's outcomes, methods to identification, therapy, and aftercare can vary substantially. For case, the American often relies a more fragmented system, potentially leading to shorter periods of w